Skip to content

A longitudinal study for prescription and over-the-counter drug use disorder

A longitudinal study for prescription and over-the-counter drug use disorder - A longitudinal study for prescription and OTC use disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000054785
Enrollment
100
Registered
2024-06-27
Start date
2024-04-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prescription and over-the-counter drug use disorders

Interventions

None listed

Sponsors

National Center of Neurology and Psychiatry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals diagnosed with prescription drug and/or over-the-counter drug use disorder who regularly visit NCNP hospital

Exclusion criteria

Exclusion criteria: In case that primary care physician concerns worsening of symptoms by participating in this study

Design outcomes

Primary

MeasureTime frame
Self efficacy Scale for Drug Dependence, SOCRATES-8D, UCLA Loneliness Scale. Beck Depression Inventory, Beck Anxiety Inventory, Difficulties in Emotion Regulation Scale, The 20-items Toronto Alexithymia Scale

Countries

Japan

Contacts

Public ContactYumi Saito

National Center of Neurology and Psychiatry Department of Psychiatry

ysaito@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026